Randomized Phase II trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor receptor 2/neu

Amanda N. Fader, Dana M. Roque, Eric Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko K. Chambers, Angeles Alvarez Secord, Laura Havrilesky, David M. O'Malley, Floor Backes, Nicole Nevadunsky, Babak Edraki, Dirk Pikaart, William Lowery, Karim S. El Sahwi, Paul Celano, Stefania Bellone, Masoud Azodi, Babak LitkouhiElena Ratner, Dan Arin Silasi, Peter E. Schwartz, Alessandro D. Santin

Research output: Contribution to journalArticlepeer-review

176 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized Phase II trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor receptor 2/neu'. Together they form a unique fingerprint.

Medicine & Life Sciences